83_FR_10781 83 FR 10733 - Bright Futures Periodicity Schedule Updates

83 FR 10733 - Bright Futures Periodicity Schedule Updates

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration

Federal Register Volume 83, Issue 48 (March 12, 2018)

Page Range10733-10734
FR Document2018-04834

Effective December 21, 2017, HRSA updated the HRSA-supported guidelines for infants, children, and adolescents for purposes of health insurance coverage for preventive services, as set out in the Bright Futures Periodicity Schedule. This notice serves as an announcement of the decision to update these guidelines as listed below. Please see https://mchb.hrsa.gov/maternal-child-health-topics/ child-health/bright-futures.html for additional information.

Federal Register, Volume 83 Issue 48 (Monday, March 12, 2018) 
[Federal Register Volume 83, Number 48 (Monday, March 12, 2018)]
[Notices]
[Pages 10733-10734]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-04834]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


Bright Futures Periodicity Schedule Updates

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Effective December 21, 2017, HRSA updated the HRSA-supported 
guidelines for infants, children, and adolescents for purposes of 
health insurance coverage for preventive services, as set out in the 
Bright Futures Periodicity Schedule. This notice serves as an 
announcement of the decision to update these guidelines as listed 
below. Please see https://mchb.hrsa.gov/maternal-child-health-topics/child-health/bright-futures.html for additional information.

FOR FURTHER INFORMATION CONTACT: Bethany D. Miller, LCSW-C, M.Ed., 
HRSA/Maternal and Child Health Bureau by calling (301) 495-5156 or 
emailing BMiller@hrsa.gov.

SUPPLEMENTARY INFORMATION: The Bright Futures program has been funded 
by HRSA since 1990. A primary focus of this program is for the funding 
recipient to maintain and update the Bright Futures Guidelines for 
Health Supervision of Infants, Children and Adolescents, a set of 
materials and tools that provide theory-based and evidence-driven 
guidance for all preventive care screenings and well-child visits. One 
component of these tools is the Bright Futures Periodicity Schedule, a 
chart

[[Page 10734]]

that outlines the recommended screenings, assessments, physical 
examinations, and procedures to be delivered during preventive checkups 
at each age milestone. The Bright Futures Periodicity Schedule has 
become the accepted schedule within the United States for preventive 
health services through the course of a child's development.
    Section 2713 of the Public Health Service Act requires that non-
grandfathered group health plans and health insurance issuers offering 
group or individual health insurance coverage provide coverage for 
certain preventive health services in four identified areas without 
cost sharing. Section 2713(a)(3) describes such services for infants, 
children, and adolescents as ``evidence-informed preventive care and 
screenings provided for in the comprehensive guidelines supported by 
HRSA.'' HHS, along with the Departments of Treasury and Labor, issued 
an Interim Final Rule (IFR) on July 19, 2010 (75 FR 41726-41760) that 
identified two specific charts as the comprehensive guidelines 
supported by HRSA for infants, children, and adolescents to be covered 
by insurance without cost sharing by non-grandfathered group health 
plans and health insurance issuers: (1) The Bright Futures Periodicity 
Schedule and (2) the Recommended Uniform Screening Panel (RUSP) of the 
Advisory Committee on Heritable Disorders in Newborns and Children. The 
IFR provided that future changes to these comprehensive guidelines are 
considered to be issued for purposes of Section 2713 on the date of 
acceptance by the HRSA Administrator or, if applicable, adoption by the 
Secretary.
    On December 21, 2017, the HRSA Administrator accepted the proposed 
2017 updates to the Bright Futures Periodicity Schedule. Therefore, all 
non-grandfathered group health plans and health insurance issuers 
offering group or individual health insurance coverage must cover the 
services and screenings listed on the updated Bright Futures 
Periodicity Schedule for plan years (in the individual market, policy 
years) beginning on or after December 21, 2018.
    The updated 2017 Bright Futures Periodicity schedule can be 
accessed at the following link: https://mchb.hrsa.gov/maternal-child-health-topics/child-health/bright-futures.html.

    Dated: February 27, 2018.
George Sigounas,
Administrator.
[FR Doc. 2018-04834 Filed 3-9-18; 8:45 am]
 BILLING CODE 4165-15-P

Federal Register / Vol. 83, No. 48 / Monday, March 12, 2018 / Notices 10733 do not wish to be made available to the Docket: For access to the docket to subject to review by the Office of public, submit the comment as a read background documents or the Management and Budget (OMB) under written/paper submission and in the electronic and written/paper comments the Paperwork Reduction Act of 1995 manner detailed (see ‘‘Written/Paper received, go to https:// (44 U.S.C. 3501–3520). The collections Submissions’’ and ‘‘Instructions’’). www.regulations.gov and insert the of information in 21 CFR part 514 have docket number, found in brackets in the been approved under OMB control Written/Paper Submissions heading of this document, into the numbers 0910–0032 and 0910–0699; 21 Submit written/paper submissions as ‘‘Search’’ box and follow the prompts CFR part 511 have been approved under follows: and/or go to the Dockets Management OMB control number 0910–0117. • Mail/Hand delivery/Courier (for Staff, 5630 Fishers Lane, Rm. 1061, IV. Electronic Access written/paper submissions): Dockets Rockville, MD 20852. Management Staff (HFA–305), Food and You may submit comments on any Persons with access to the internet Drug Administration, 5630 Fishers guidance at any time (see 21 CFR may obtain the draft guidance at either Lane, Rm. 1061, Rockville, MD 20852. 10.115(g)(5)). http://www.fda.gov/AnimalVeterinary/ • For written/paper comments Submit written requests for single GuidanceComplianceEnforcement/ submitted to the Dockets Management copies of the guidance to the Policy and GuidanceforIndustry/default.htm or Staff, FDA will post your comment, as Regulations Staff (HFV–6), Center for https://www.regulations.gov. well as any attachments, except for Veterinary Medicine, Food and Drug Dated: March 6, 2018. information submitted, marked and Administration, 7500 Standish Pl., Leslie Kux, identified, as confidential, if submitted Rockville, MD 20855. Send one self- Associate Commissioner for Policy. as detailed in ‘‘Instructions.’’ addressed adhesive label to assist that [FR Doc. 2018–04885 Filed 3–9–18; 8:45 am] office in processing your requests. See Instructions: All submissions received BILLING CODE 4164–01–P the SUPPLEMENTARY INFORMATION section must include the Docket No. FDA– for electronic access to the draft 2018–D–0626 for ‘‘Proprietary Names guidance document. for New Animal Drugs.’’ Received DEPARTMENT OF HEALTH AND FOR FURTHER INFORMATION CONTACT: Tom comments will be placed in the docket HUMAN SERVICES and, except for those submitted as Modric, Center for Veterinary Medicine ‘‘Confidential Submissions,’’ publicly (HFV–216), Food and Drug Health Resources and Service viewable at https://www.regulations.gov Administration, 7519 Standish Pl., Administration or at the Dockets Management Staff Rockville, MD 20855, 240–402–5853, between 9 a.m. and 4 p.m., Monday tomislav.modric@fda.hhs.gov. Bright Futures Periodicity Schedule through Friday. SUPPLEMENTARY INFORMATION: Updates • Confidential Submissions—To I. Background AGENCY: Health Resources and Service submit a comment with confidential FDA is announcing the availability of Administration (HRSA), Department of information that you do not wish to be a draft guidance for industry #240 Health and Human Services (HHS). made publicly available, submit your entitled ‘‘Proprietary Names for New ACTION: Notice. comments only as a written/paper Animal Drugs.’’ CVM evaluates submission. You should submit two SUMMARY: Effective December 21, 2017, proprietary names as a part of the new HRSA updated the HRSA-supported copies total. One copy will include the animal drug approval process. Selecting information you claim to be confidential guidelines for infants, children, and a proprietary name is a critical element adolescents for purposes of health with a heading or cover note that states in the design and development of drug ‘‘THIS DOCUMENT CONTAINS insurance coverage for preventive product labeling because end users may services, as set out in the Bright Futures CONFIDENTIAL INFORMATION.’’ The rely, in part, on the proprietary name to Agency will review this copy, including Periodicity Schedule. This notice serves identify which product, among as an announcement of the decision to the claimed confidential information, in thousands of available products, is its consideration of comments. The update these guidelines as listed below. intended for a given animal. Please see https://mchb.hrsa.gov/ second copy, which will have the claimed confidential information II. Significance of Guidance maternal-child-health-topics/child- redacted/blacked out, will be available This level 1 draft guidance is being health/bright-futures.html for additional for public viewing and posted on issued consistent with FDA’s good information. https://www.regulations.gov. Submit guidance practices regulation (21 CFR FOR FURTHER INFORMATION CONTACT: both copies to the Dockets Management 10.115). The draft guidance, when Bethany D. Miller, LCSW–C, M.Ed., Staff. If you do not wish your name and finalized, will represent the current HRSA/Maternal and Child Health contact information to be made publicly thinking of FDA on ‘‘Proprietary Names Bureau by calling (301) 495–5156 or available, you can provide this for New Animal Drugs.’’ It does not emailing BMiller@hrsa.gov. information on the cover sheet and not establish any rights for any person and SUPPLEMENTARY INFORMATION: The Bright in the body of your comments and you is not binding on FDA or the public. Futures program has been funded by must identify this information as You can use an alternative approach if HRSA since 1990. A primary focus of ‘‘confidential.’’ Any information marked it satisfies the requirements of the this program is for the funding recipient as ‘‘confidential’’ will not be disclosed applicable statutes and regulations. This to maintain and update the Bright except in accordance with 21 CFR 10.20 is not a significant regulatory action Futures Guidelines for Health amozie on DSK30RV082PROD with NOTICES and other applicable disclosure law. For subject to Executive Order 12866. Supervision of Infants, Children and more information about FDA’s posting Adolescents, a set of materials and tools of comments to public dockets, see 80 III. Paperwork Reduction Act of 1995 that provide theory-based and evidence- FR 56469, September 18, 2015, or access This draft guidance refers to driven guidance for all preventive care the information at: https://www.gpo.gov/ previously approved collections of screenings and well-child visits. One fdsys/pkg/FR-2015-09-18/pdf/2015- information found in FDA regulations. component of these tools is the Bright 23389.pdf. These collections of information are Futures Periodicity Schedule, a chart VerDate Sep<11>2014 18:12 Mar 09, 2018 Jkt 244001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\12MRN1.SGM 12MRN1

10734 Federal Register / Vol. 83, No. 48 / Monday, March 12, 2018 / Notices that outlines the recommended DEPARTMENT OF HEALTH AND Agenda: To review and evaluate personal screenings, assessments, physical HUMAN SERVICES qualifications and performance, and examinations, and procedures to be competence of individual investigators. National Institutes of Health Place: Residence Inn Bethesda, 7335 delivered during preventive checkups at Wisconsin Avenue, Bethesda, MD 20814. each age milestone. The Bright Futures Contact Person: Alan P. Koretsky, Ph.D., Periodicity Schedule has become the Eunice Kennedy Shriver National Scientific Director, Division of Intramural accepted schedule within the United Institute of Child Health & Human Research, National Institute of Neurological States for preventive health services Development; Amended Notice of Disorders and Stroke, NIH, 35 Convent Drive, through the course of a child’s Meeting Room 6A 908, Bethesda, MD 20892, (301) development. 435–2232, koretskya@ninds.nih.gov. Notice is hereby given of a change in (Catalogue of Federal Domestic Assistance Section 2713 of the Public Health the meeting of the National Institute of Program Nos. 93.853, Clinical Research Service Act requires that non- Child Health and Human Development Related to Neurological Disorders; 93.854, grandfathered group health plans and Special Emphasis Panel, March 2, 2018, Biological Basis Research in the health insurance issuers offering group 8:30 a.m. to March 2, 2018, 5:00 p.m., Neurosciences, National Institutes of Health, or individual health insurance coverage Hilton Washington/Rockville, 1750 HHS). provide coverage for certain preventive Rockville Pike, Rockville, MD, 20852 Dated: March 6, 2018. health services in four identified areas which was published in the Federal Sylvia l. Neal, without cost sharing. Section 2713(a)(3) Register on February 6, 2018, 83 FR describes such services for infants, Program Analyst, Office of Federal Advisory 5265. Committee Policy. children, and adolescents as ‘‘evidence- informed preventive care and screenings The meeting date has changed from [FR Doc. 2018–04951 Filed 3–9–18; 8:45 am] provided for in the comprehensive March 2, 2018 from 8:30 a.m. to 5:00 BILLING CODE 4140–01–P guidelines supported by HRSA.’’ HHS, p.m. to March 13, 2018 from 10:30 a.m. along with the Departments of Treasury to 3:30 p.m. The meeting is closed to the and Labor, issued an Interim Final Rule public. DEPARTMENT OF HEALTH AND (IFR) on July 19, 2010 (75 FR 41726– Dated: March 6, 2018. HUMAN SERVICES 41760) that identified two specific Michelle Trout, National Institutes of Health charts as the comprehensive guidelines Program Analyst, Office of Federal Advisory supported by HRSA for infants, Committee Policy. Proposed Collection; 60-Day Comment children, and adolescents to be covered [FR Doc. 2018–04949 Filed 3–9–18; 8:45 am] Request; Generic Clearance for the by insurance without cost sharing by BILLING CODE 4140–01–P Collection of Qualitative Feedback on non-grandfathered group health plans Agency Service Delivery (National and health insurance issuers: (1) The Institute of Nursing Research) Bright Futures Periodicity Schedule and DEPARTMENT OF HEALTH AND (2) the Recommended Uniform HUMAN SERVICES AGENCY: National Institutes of Health, Screening Panel (RUSP) of the Advisory HHS. Committee on Heritable Disorders in National Institutes of Health ACTION: Notice. Newborns and Children. The IFR National Institute of Neurological SUMMARY: In compliance with the provided that future changes to these Disorders and Stroke; Notice of Closed requirement of the Paperwork comprehensive guidelines are Meeting Reduction Act of 1995 to provide considered to be issued for purposes of opportunity for public comment on Section 2713 on the date of acceptance Pursuant to section 10(d) of the proposed data collection projects, the by the HRSA Administrator or, if Federal Advisory Committee Act, as National Institute of Nursing Research applicable, adoption by the Secretary. amended, notice is hereby given of a (NINR) will publish periodic summaries On December 21, 2017, the HRSA of propose projects to be submitted to Administrator accepted the proposed meeting of the Board of Scientific Counselors, National Institute of the Office of Management and Budget 2017 updates to the Bright Futures (OMB) for review and approval. Periodicity Schedule. Therefore, all Neurological Disorders and Stroke. DATES: Comments regarding this non-grandfathered group health plans The meeting will be closed to the public as indicated below in accordance information collection are best assured and health insurance issuers offering with the provisions set forth in sections of having their full effect if received group or individual health insurance 552b(c)(6), Title 5 U.S.C., as amended within 60 days of the date of this coverage must cover the services and for the review, discussion, and publication. screenings listed on the updated Bright Futures Periodicity Schedule for plan evaluation of individual intramural FOR FURTHER INFORMATION CONTACT: To years (in the individual market, policy programs and projects conducted by the obtain a copy of the data collection years) beginning on or after December National Institute of Neurological plans and instruments, submit 21, 2018. Disorders and Stroke, including comments in writing, or request more The updated 2017 Bright Futures consideration of personnel information on the proposed project, Periodicity schedule can be accessed at qualifications and performance, and the contact: Diana Finegold, Division of the following link: https:// competence of individual investigators, Science Policy and Public Liaison, mchb.hrsa.gov/maternal-child-health- the disclosure of which would NINR, NIH, 31 Center Drive, Building amozie on DSK30RV082PROD with NOTICES topics/child-health/bright-futures.html. constitute a clearly unwarranted 31, Suite B1B55, Bethesda, MD 20892, invasion of personal privacy. by phone at (301) 496–0209 or email Dated: February 27, 2018. your request, including your address to: George Sigounas, Name of Committee: Board of Scientific Counselors, National Institute of diana.finegold@nih.gov. Formal Administrator. requests for additional plans and Neurological Disorders and Stroke. [FR Doc. 2018–04834 Filed 3–9–18; 8:45 am] Date: April 15–17, 2018. instruments must be requested in BILLING CODE 4165–15–P Time: 6:00 p.m. to 12:00 p.m. writing. VerDate Sep<11>2014 18:12 Mar 09, 2018 Jkt 244001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\12MRN1.SGM 12MRN1


Document Created: 2018-11-01 08:51:40
Document Modified: 2018-11-01 08:51:40
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
ContactBethany D. Miller, LCSW-C, M.Ed., HRSA/Maternal and Child Health Bureau by calling (301) 495-5156 or emailing [email protected]
FR Citation83 FR 10733 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR